Literature DB >> 27553208

Determinants of Change in the Cost-effectiveness Threshold.

Mike Paulden1, James O'Mahony2, Christopher McCabe1.   

Abstract

The cost-effectiveness threshold in health care systems with a constrained budget should be determined by the cost-effectiveness of displacing health care services to fund new interventions. Using comparative statics, we review some potential determinants of the threshold, including the budget for health care, the demand for existing health care interventions, the technical efficiency of existing interventions, and the development of new health technologies. We consider the anticipated direction of impact that would affect the threshold following a change in each of these determinants. Where the health care system is technically efficient, an increase in the health care budget unambiguously raises the threshold, whereas an increase in the demand for existing, non-marginal health interventions unambiguously lowers the threshold. Improvements in the technical efficiency of existing interventions may raise or lower the threshold, depending on the cause of the improvement in efficiency, whether the intervention is already funded, and, if so, whether it is marginal. New technologies may also raise or lower the threshold, depending on whether the new technology is a substitute for an existing technology and, again, whether the existing technology is marginal. Our analysis permits health economists and decision makers to assess if and in what direction the threshold may change over time. This matters, as threshold changes impact the cost-effectiveness of interventions that require decisions now but have costs and effects that fall in future periods.

Keywords:  cost-effectiveness analysis; economic analysis; economics health; pharmacoeconomics; resource allocation

Mesh:

Year:  2016        PMID: 27553208     DOI: 10.1177/0272989X16662242

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  10 in total

1.  Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Authors:  Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 2.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

3.  Cost-effectiveness of mammography from a publicly funded health care system perspective.

Authors:  Nicole Mittmann; Natasha K Stout; Anna N A Tosteson; Amy Trentham-Dietz; Oguzhan Alagoz; Martin J Yaffe
Journal:  CMAJ Open       Date:  2018-02-08

4.  Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.

Authors:  James Lomas; Karl Claxton; Jessica Ochalek
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

5.  How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations.

Authors:  K Hauck; A Morton; K Chalkidou; Y-Ling Chi; A Culyer; C Levin; R Meacock; M Over; R Thomas; A Vassall; S Verguet; P C Smith
Journal:  Soc Sci Med       Date:  2018-11-03       Impact factor: 4.634

6.  Accounting for Timing when Assessing Health-Related Policies.

Authors:  Karl Claxton; Miqdad Asaria; Collins Chansa; Julian Jamison; James Lomas; Jessica Ochalek; Mike Paulden
Journal:  J Benefit Cost Anal       Date:  2019-01-26

7.  Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.

Authors:  Chathika Krishan Weerasuriya; Rebecca Claire Harris; Matthew Quaife; Christopher Finn McQuaid; Richard G White; Gabriela B Gomez
Journal:  Vaccines (Basel)       Date:  2021-03-11

Review 8.  Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy.

Authors:  Chris Sampson; Bernarda Zamora; Sam Watson; John Cairns; Kalipso Chalkidou; Patricia Cubi-Molla; Nancy Devlin; Borja García-Lorenzo; Dyfrig A Hughes; Ashley A Leech; Adrian Towse
Journal:  Appl Health Econ Health Policy       Date:  2022-06-07       Impact factor: 3.686

9.  Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf.

Authors:  Jonathan Siverskog; Martin Henriksson
Journal:  Med Decis Making       Date:  2020-03-14       Impact factor: 2.583

10.  A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics.

Authors:  Joost W Geenen; Svetlana V Belitser; Rick A Vreman; Martijn van Bloois; Olaf H Klungel; Cornelis Boersma; Anke M Hövels
Journal:  Eur J Health Econ       Date:  2020-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.